Public submissions on scheduling matters referred to the ACMS #27, ACCS #25 and Joint ACMS-ACCS #22 meetings held in June 2019

Public submissions made in response to:

• the delegates' proposed amendments to the Poisons Standard referred to the ACMS #27 and Joint ACMS-ACCS #22 meetings published on 11 April 2019 and received before the first closing date under regulation 42ZCZK of the Therapeutic Goods Regulations 1990 (the Regulations)
• the delegates' proposed amendments to the Poisons Standard referred to the ACCS #25 meeting published on 24 April 2019 and received before the first closing date under regulation 42ZCZK of the Regulations

Public submissions on proposed amendments to be referred to an expert advisory committee

Public submissions on proposed amendments referred to the ACMS #27

Sanguinarine

Finasteride

Phenpromethamine

1,4-dimethylpentylamine (DMPA)

Public submissions on proposed amendments referred to the Joint ACMS-ACCS #22

Arbutin

Public submissions on proposed amendments referred to the ACCS #25

No public submissions were received in response to the ACCS #25 for sarolaner, broflanilide, saflufenacil, trifludmoxazin or lambda-cyhalothrin.